Koers Inspyr Therapeutics Inc OTC Bulletin Board
Aandelen
Biotechnologie & Medisch Onderzoek
slotkoers
Andere beurzen
|
||
- USD | - |
|
Omzet 2021 | - | Omzet 2022 | - | Marktkapitalisatie | 241K 223K |
---|---|---|---|---|---|
Nettowinst (verlies) 2021 | 2 mln. 1,85 mln. | Nettowinst (verlies) 2022 | -1 mln. -925K | EV/omzet 2021 | - |
Nettoliquiditeiten 2021 | 197K 182K | Nettoschuld 2022 | 305K 282K | EV/omzet 2022 | - |
K/w-verhouding 2021 |
-0,4
x | K/w-verhouding 2022 |
-0,23
x | Werknemers | - |
Dividendrendement 2021 * |
-
| Dividendrendement 2022 |
-
| Vrij verhandelbaar | 100% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Silvestre Raul
CEO | Chief Executive Officer | 53 | - |
Michael Elliott
CTO | Chief Tech/Sci/R&D Officer | - | 11-10-16 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Scott Ogilvie
BRD | Director/Board Member | 69 | 01-02-08 |
Silvestre Raul
CEO | Chief Executive Officer | 53 | - |
Claire Thomas
BRD | Director/Board Member | 68 | 12-10-16 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+16,61% | 122 mld. | |
+17,75% | 112 mld. | |
+17,23% | 25,91 mld. | |
-24,11% | 19,33 mld. | |
-18,56% | 16,17 mld. | |
-18,47% | 15,6 mld. | |
-47,75% | 14,65 mld. | |
+57,35% | 14,34 mld. | |
+5,62% | 14 mld. |
- Beurs
- Aandelen
- Koers RBSH
- Koers